{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:30:42Z","timestamp":1790213442486,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.4065\/74.5.519","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"519-528","source":"Crossref","is-referenced-by-count":45,"title":["The Aminoglycosides"],"prefix":"10.4065","volume":"74","author":[{"given":"Randall S.","family":"Edson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Terrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/74.5.519_bib1","first-page":"821828","article-title":"Studies on antibiotic synergism against enterococci. I. Bacteriologie studies","volume":"77","author":"Moellering","year":"1971","journal-title":"J Lab Clin Med"},{"key":"10.4065\/74.5.519_bib2","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1172\/JCI106758","article-title":"Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake of 14C-labeled streptomycin by enterococci","volume":"50","author":"Moellering","year":"1971","journal-title":"J Clin Invest"},{"key":"10.4065\/74.5.519_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/MMBR.51.3.341-350.1987","article-title":"Mechanism of bactericidal action of aminoglycosides","volume":"51","author":"Davis","year":"1987","journal-title":"Microbiol Rev"},{"key":"10.4065\/74.5.519_bib4","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.83.16.6164","article-title":"Misread protein creates membrane channels: an essential step in the bactericidal action of amino-glycosides","volume":"83","author":"Davis","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.4065\/74.5.519_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-73-3-393","article-title":"Deafness complicating antibiotic therapy of hepatic encephalopathy","volume":"73","author":"Berk","year":"1970","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.4065\/74.5.519_bib6","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/124.Supplement_1.S98","article-title":"Pharmacology of gentamicin in man","volume":"124","author":"Riff","year":"1971","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/infdis\/132.6.637","article-title":"Pharmaco-Kinetics of gentamicin in children and adults","volume":"132","author":"Slber","year":"1975","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/106002809402800719","article-title":"Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups","volume":"28","author":"Dager","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.5.519_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/AAC.2.3.214","article-title":"Serum protein binding of the aminoglycoside antibiotics","volume":"2","author":"Gordon","year":"1972","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/5.1.95","article-title":"The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences","volume":"5","author":"Walker","year":"1979","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.5.519_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/clpt.1986.47","article-title":"Factors affecting aminoglycoside disposition: effects of circadian rhythm and dietary protein intake on gentamicin pharmacokinetics","volume":"39","author":"Dickson","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/74.5.519_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/AAC.3.1.125","article-title":"Tobramycin and gentamicin concentrations in the serum of normal and anephric patients","volume":"3","author":"Lockwood","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"10.4065\/74.5.519_bib13","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1093\/infdis\/135.Supplement_2.S343","article-title":"Pharmacokinetics of amikacin in patients with impaired renal function","volume":"134","author":"McHenry","year":"1976","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/AAC.11.2.214","article-title":"Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis","volume":"11","author":"Regeur","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0272-6386(12)70321-9","article-title":"Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers","volume":"22","author":"Agarwal","year":"1993","journal-title":"Am J kidey Dis"},{"key":"10.4065\/74.5.519_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/AAC.15.1.131","article-title":"Autoradiographic localization of [3H)gentamicin in the proximal renal tubules of mice","volume":"15","author":"Kuhar","year":"1979","journal-title":"Antimicrob Agents Chemotner"},{"key":"10.4065\/74.5.519_bib17","first-page":"181","article-title":"Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis","volume":"21","author":"Goitein","year":"1975","journal-title":"Ctemolherapy"},{"key":"10.4065\/74.5.519_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.13.6.1042","article-title":"Cerebrospinal fluid penetration of amikacin","volume":"13","author":"Briedis","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.34.2.269","article-title":"Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia","volume":"341","author":"Brown","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib20","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199306173282403","article-title":"Efficacy of aerosolized tobramycin in patients with cystic fibrosis","volume":"328","author":"Ramsay","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4065\/74.5.519_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.1950060207","article-title":"Long-term tobramycin aerosol therapy in cystic fibrosis","volume":"6","author":"Steinkamp","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"10.4065\/74.5.519_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.1950070110","article-title":"Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa","volume":"7","author":"MacLusky","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"10.4065\/74.5.519_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"New Engl J Med"},{"key":"10.4065\/74.5.519_bib24","first-page":"637","article-title":"The penetration of gentamicin into the vitreous humor in man","volume":"24","author":"Rubanstein","year":"1983","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.4065\/74.5.519_bib25","first-page":"92","article-title":"Concentration of gentamicin in serum, urine and urogenital tissue in man","volume":"241","author":"Aifthan","year":"1973","journal-title":"Acta Pathol Microbiol Scand (B) Suppl"},{"key":"10.4065\/74.5.519_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/127.3.299","article-title":"Gentamicin levels in the human biliary tract","volume":"127","author":"Pitt","year":"1973","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/infdis\/142.4.586","article-title":"Gentamicin inactivation in purulent exudates: role of cell lysis","volume":"142","author":"Vaudaux","year":"1980","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib28","doi-asserted-by":"crossref","first-page":"541545","DOI":"10.1093\/infdis\/138.4.541","article-title":"Comparative nephrotoxicity of aminoglycoside antibiotics in rats","volume":"138","author":"Luft","year":"1978","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0140-6736(75)91197-6","article-title":"Prolonged excretion of gentamicin in a patient with unimpaired renal function [letter]","volume":"1","author":"Kahimeter","year":"1975","journal-title":"Lancet"},{"key":"10.4065\/74.5.519_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.31.4.485","article-title":"Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection","volume":"31","author":"Ho","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.4065\/74.5.519_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/31.suppl_A.67","article-title":"Treatment of intra-abdominal infections","volume":"31","author":"Gorbach","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.5.519_bib32","first-page":"1127","article-title":"Monotherapy versus \u03b2-lactam aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study [published erratum appears in Antimicrob Agents Chemother 1997:41:2595)","volume":"41","author":"Leibovicl","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","article-title":"1997 guidelines for the use of antimicrobial agents in neutropenic patients with unex plained fever","volume":"25","author":"Hughes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib34","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","article-title":"Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia","volume":"317","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1987","journal-title":"N Engl J Med"},{"key":"10.4065\/74.5.519_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/clinids\/19.1.42","article-title":"Streptomycin and alternative agents for the treatment of tularemia: review of the literature","volume":"19","author":"Enderlin","year":"1994","journal-title":"Clin infect Dis"},{"key":"10.4065\/74.5.519_bib36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-121-11-199412010-00009","article-title":"Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users","volume":"121","author":"DINublle","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.5.519_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/AAC.41.1.80","article-title":"Treatment of human brucellosis with doxycycline and gentamicin","volume":"41","author":"Solera","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib38","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/clinids\/21.6.1406","article-title":"Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective mulucenter study","volume":"21","author":"Francloli","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-100-2-219","article-title":"Five-year surveillance of aminoglycoside usage in a university hospital","volume":"100","author":"Betts","year":"1984","journal-title":"Ann Intern Med"},{"issue":"Suppl lA","key":"10.4065\/74.5.519_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(85)90189-5","article-title":"Three-year experience with amikacin sulfate as an exclusive surgical aminoglycoside in a large acute-care hospital","volume":"79","author":"Lee","year":"1985","journal-title":"Am J Med"},{"issue":"Suppl 6B","key":"10.4065\/74.5.519_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(86)90475-4","article-title":"Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985","volume":"80","author":"Gerding","year":"1986","journal-title":"Am J Med"},{"key":"10.4065\/74.5.519_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/joc.1996.8.1.17","article-title":"Amikacin as first-choice aminoglycoside m a medical intensive care unit: a one-year bacteriological surveillance study","volume":"8","author":"Peetermans","year":"1996","journal-title":"J Chemother"},{"key":"10.4065\/74.5.519_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.29.1.150","article-title":"Successful treatment of a pancreatic Nocardia asteroides abscess with amikacin and surgical drainage","volume":"29","author":"Meler","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AAC.24.5.810","article-title":"Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides","volume":"24","author":"Gombert","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib45","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/AAC.32.12.1776","article-title":"Antimicrobial susceptibility patterns of Nocardia asteroides","volume":"32","author":"Wallace","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-113-5-358","article-title":"Treatment of disseminated mycobacterium avium complex infection in AIDS with amikacin, ethambutol. rifampin. and ciprofloxacin","volume":"113","author":"Chiu","year":"1990","journal-title":"Ann tntern Med"},{"key":"10.4065\/74.5.519_bib47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/152.3.500","article-title":"Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities","volume":"152","author":"Wallace","year":"1985","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib48","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/515038","article-title":"Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci","volume":"27","author":"Sexton","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib49","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/archinte.1986.00360240043008","article-title":"Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients","volume":"146","author":"Bernstein","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.5.519_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/AAC.39.2.545","article-title":"Aminoglycoside dosing weight correction factors for patients of various body sizes","volume":"39","author":"Traynor","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib51","first-page":"132","article-title":"Dosage nomograms for aminoglycoside antibiotics","volume":"16","author":"KL Spyker","year":"1981","journal-title":"Hosp Formulary"},{"key":"10.4065\/74.5.519_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.4065\/74.5.519_bib53","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/106002809202600503","article-title":"Predictive performance of equations to estimate creatinine clearance in hospitalized elderly patients","volume":"26","author":"O'Connell","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.5.519_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(84)90358-9","article-title":"Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia","volume":"77","author":"Moore","year":"1984","journal-title":"Am J Med"},{"key":"10.4065\/74.5.519_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/149.3.443","article-title":"The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia","volume":"149","author":"Moore","year":"1984","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9343(76)90328-4","article-title":"Simultaneous antibiotic levels in \u201cbreakthrough\u201d gram-negative rod bacteremia","volume":"61","author":"Anderson","year":"1976","journal-title":"Am j Med"},{"key":"10.4065\/74.5.519_bib58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/clinids\/14.1.320","article-title":"A critical reevaluation of the \u201ctherapeutic range\u201d of aminoglycosides","volume":"14","author":"McCormack","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3476(86)80722-3","article-title":"Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective","volume":"109","author":"Massey","year":"1986","journal-title":"J Pediatr"},{"key":"10.4065\/74.5.519_bib60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/140.4.576","article-title":"The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure","volume":"140","author":"Bennett","year":"1979","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/j.1875-9114.1995.tb04368.x","article-title":"Single daily dosing of aminoglycosides","volume":"15","author":"Preston","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.4065\/74.5.519_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00019048-199601000-00004","article-title":"Once-daily aminoglycoside treatment","volume":"5","author":"Dew","year":"1996","journal-title":"Infect Dis Clin Pract"},{"key":"10.4065\/74.5.519_bib63","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/clinids\/24.5.786","article-title":"A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides","volume":"24","author":"Bailey","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib64","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/clinids\/24.5.796","article-title":"A meta-analysis of trie relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides","volume":"24","author":"Ali","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib65","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/clinids\/24.5.810","article-title":"Single daily dosing of aminoglycosides In immunocompromised adults: a systematic review","volume":"24","author":"Hatala","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.5.519_bib66","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1128\/AAC.34.12.2387","article-title":"Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis","volume":"34","author":"Fantin","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib67","first-page":"561","article-title":"Once-daily aminoglycosides [published erratum appears in Conn Med 1992:56:694]","volume":"56","author":"Nicolau","year":"1992","journal-title":"Conn Med"},{"key":"10.4065\/74.5.519_bib68","first-page":"279","article-title":"Aminoglycosides","volume":"Vol l","author":"Gilbert","year":"1995"},{"issue":"Suppl A","key":"10.4065\/74.5.519_bib69","first-page":"l","article-title":"General mechanisms of resistance to antibiotics","volume":"22","author":"Bryan","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.4065\/74.5.519_bib70","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1093\/clinids\/5.Supplement_2.S261","article-title":"Resistance to aminoglycosides: mechanisms and frequency","volume":"5","author":"Davies","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"Suppl 6B","key":"10.4065\/74.5.519_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0002-9343(86)90479-1","article-title":"Prevalence and mechanisms of aminoglycoside resistance: a ten-year study","volume":"80","author":"Phillips","year":"1986","journal-title":"Am J Med"},{"issue":"Suppl 6B","key":"10.4065\/74.5.519_bib72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(86)90481-X","article-title":"Susceptibility of aerobic gram-negative bacilli to aminoglycosides: effects of 45 months of amikacin as first-line aminoglycoside therapy","volume":"80","author":"Saavedra","year":"1986","journal-title":"Am J Med"},{"issue":"Suppl 6B","key":"10.4065\/74.5.519_bib73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(86)90482-1","article-title":"Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin","volume":"80","author":"Ruiz-Paiacios","year":"1986","journal-title":"Am J Med"},{"key":"10.4065\/74.5.519_bib74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/AAC.12.3.401","article-title":"Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin","volume":"12","author":"Calderwood","year":"1977","journal-title":"Antimrcrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib75","first-page":"233","article-title":"A multicenter study of the epidemiology of enterococcal infections [abstract|","volume":"29","author":"Gordon","year":"1989","journal-title":"Program Abstr Intersci Conf Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib76","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/archinte.1989.00390080123026","article-title":"Endocarditis due to streptomycin susceptible Enterococcus faecalis with high-level gentamicin resistance","volume":"149","author":"Spiegel","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.5.519_bib77","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-106-5-687","article-title":"Nosocomial infection by gentamicin-resistant Streptococcus faecalis","volume":"106","author":"Zervos","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.5.519_bib78","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archinte.1986.00360200111018","article-title":"Nosocomial urinary tract infections due to Enterococcus: ten years' experience at a university hospital","volume":"146","author":"Morrison","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.5.519_bib79","first-page":"207","article-title":"Aminoglycoside toxicity and relation to dose regimen","volume":"13","author":"Barclay","year":"1994","journal-title":"Adverse Drug React Toxicof Rev"},{"key":"10.4065\/74.5.519_bib80","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM198005153022002","article-title":"Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin","volume":"302","author":"Smith","year":"1980","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"10.4065\/74.5.519_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/13.suppl_A.9","article-title":"Aminoglycoside toxicity\u2014a review of clinical studies published between 1975 and 1982","volume":"13","author":"Kahlmeter","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.5.519_bib82","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.1980.03310160024018","article-title":"Clinical nephrotoxicity of tobramycin and gentamicin: a prospective study","volume":"244","author":"Kumin","year":"1980","journal-title":"JAMA"},{"issue":"Suppl 6B","key":"10.4065\/74.5.519_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9343(86)90487-0","article-title":"Experimental studies on nephrotoxicity of aminoglycosides at low doses: mechanisms and perspectives,","volume":"80","author":"Tulkens","year":"1986","journal-title":"Am J Med"},{"key":"10.4065\/74.5.519_bib84","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-107-6-900","article-title":"What is the cost of nephrotoxicity associated with aminoglycosides?","volume":"107","author":"Eisenberg","year":"1987","journal-title":"Ann intern Med"},{"key":"10.4065\/74.5.519_bib85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/167.1.173","article-title":"Incidence of and significant risk factors for aminoglycoside associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring","volume":"167","author":"Bertino","year":"1993","journal-title":"j infect Dis"},{"key":"10.4065\/74.5.519_bib86","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0002-9343(87)90947-8","article-title":"Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin treatment","volume":"83","author":"Cimino","year":"1987","journal-title":"Am J Med"},{"key":"10.4065\/74.5.519_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/32.2.325","article-title":"Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination [published erratum appears in J Antimicrob Chemother 1993:32:925].;","volume":"32","author":"Goetz","year":"1993","journal-title":"Antimicrob Chemother"},{"key":"10.4065\/74.5.519_bib88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.V4181","article-title":"Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy?","volume":"4","author":"Leehey","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.4065\/74.5.519_bib89","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.31.9.1383","article-title":"Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides","volume":"31","author":"Gatell","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.5.519_bib90","series-title":"Clinical Anesthesia","first-page":"398","article-title":"Muscle relaxants","author":"Bevan","year":"1997"},{"key":"10.4065\/74.5.519_bib91","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/159.5.945","article-title":"Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity","volume":"159","author":"Gilbert","year":"1989","journal-title":"J Infect Dis"},{"key":"10.4065\/74.5.519_bib92","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/j.1875-9114.1997.tb03760.x","article-title":"Pharmacoeconomic impact of once-daily aminoglycoside administration","volume":"17","author":"Hitt","year":"1997","journal-title":"Pharmacotherapy"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611651343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611651343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:22:32Z","timestamp":1709986952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611651343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0025619611651343"],"URL":"https:\/\/doi.org\/10.4065\/74.5.519","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}